ALTERATION OF TUMOR-GROWTH BY ASPIRIN AND INDOMETHACIN - STUDIES WITH 2 TRANSPLANTABLE TUMORS IN MOUSE
ALTERATION OF TUMOR-GROWTH BY ASPIRIN AND INDOMETHACIN - STUDIES WITH 2 TRANSPLANTABLE TUMORS IN MOUSE
复制标题
DOI:
10.1016/0014-2999(76)90044-3
复制
发表时间:
1976-01-01
影响因子:
5
通讯作者:
BEAVEN, MA
中科院分区:
文献类型:
--
作者:
HIAL, V;HORAKOVA, Z;BEAVEN, MA
Oral daily administration of aspirin or indomethacin retarded growth of experimental tumors in mice. Aspirin treatment, 150 mg/kg twice daily, inhibited growth of a transplantable mast cell ascites tumor (P815) by 39-43% (P < 0.001) and a s.c. transplanted Lewis lung carcinoma by 52% (P < 0.025) without adversely affecting body growth. The total serotonin, histamine and histidine decarboxylase content of the ascites tumor was also reduced, as was urinary excretion of the amines. Treatment with 3 and 5 mg/kg indomethacin resulted in 40% (P < 0.01) and 80% (P < 0.001) reduction, respectively, in ascites tumor growth. With the higher dose of indomethacin, no tumor was observed in half of the animals inoculated with tumor, although signs of indomethacin toxicity (reduced body growth, gastric lesion) were evident in the animals.